Oncotarget

Research Papers:

Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis

Yao Yuan, Xiaohui Hou, Hui Feng, Rui Liu, Hao Xu, Wang Gong, Jing Deng, Chongkui Sun, Yijun Gao, Jieying Peng, Yingfang Wu, Jiang Li, Changyun Fang _ and Qianming Chen

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:60348-60365. https://doi.org/10.18632/oncotarget.11254

Metrics: PDF 2195 views  |   HTML 3775 views  |   ?  


Abstract

Yao Yuan1,*, Xiaohui Hou2,*, Hui Feng3,*, Rui Liu1,*, Hao Xu1, Wang Gong1, Jing Deng1, Chongkui Sun1, Yijun Gao4, Jieying Peng5, Yingfang Wu5, Jiang Li5, Changyun Fang5, Qianming Chen1

1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu China, 610041

2Department of Endodontics, School & Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai China, 200072

3Xiangya Stomatological Hospital, Central South University, Changsha, China, 410008

4Department of Stomatology, Second Xiangya Hospital, Central South University, Changsha, China, 410008

5Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China, 410008

*These authors have contributed equally to this work

Correspondence to:

Changyun Fang, email: [email protected]

Qianming Chen, email: [email protected]

Keywords: CypA, proteomics, oral submucous fibrosis, fibroblast

Received: December 20, 2015    Accepted: July 18, 2016    Published: August 12, 2016

ABSTRACT

Oral submucous fibrosis (OSF) is a pre-cancerous lesion, which is characterized by fibrosis of the oral submucosa. Despite large body of studies focusing on this disease, the molecular mechanisms underlying the progression of OSF remained unclear. In this study, 2-DE-based proteomic approaches were employed to identify the differently expressed proteins between OSF and normal tissues. In total, 88 proteins were identified with altered expression levels, including CypA. Upregulation of CypA was further validated through immunohistochemistry staining combined with Q-PCR and western blot by using clinical samples. Statistical analyses reveal that CypA expression level is correlated to the progression of OSF. Finally, functional study reveals a pro-proliferative property of CypA in fibroblast cells by using multiple in vitro models. The present data suggest that CypA might be a potential biomarker and therapeutic target for OSF, and will lead to a better understanding of OSF pathogenesis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11254